Your browser doesn't support javascript.
loading
The use of targeted ribonucleic acid (RNA)-sequencing assay in the diagnostic evaluation of acute myeloid leukaemia (AML).
Xu, Ke; Gupta, Shweta; Kaffo, Eleanor; Baker, Robert; Nacheva, Elisabeth; O'Nions, Jenny; Wilson, Andrew J; Gupta, Rajeev.
Affiliation
  • Xu K; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, London, UK. Ke.xu@nhs.net.
  • Gupta S; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK. Ke.xu@nhs.net.
  • Kaffo E; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, London, UK.
  • Baker R; University College London, London, UK.
  • Nacheva E; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, London, UK.
  • O'Nions J; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK.
  • Wilson AJ; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, London, UK.
  • Gupta R; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK.
J Hematop ; 2024 Jun 25.
Article in En | MEDLINE | ID: mdl-38916685

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Hematop Year: 2024 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Hematop Year: 2024 Document type: Article Affiliation country: United kingdom